Elevated serum Osteopontin levels and genetic polymorphisms of Osteopontin are associated with Vogt-Koyanagi-Harada disease

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 10, 2011, Pages 7084-7089

  Chu, Mingliang ^a   Yang, Peizeng ^a   Hu, Ranran ^a   Hou, Shengping ^a   Li, Fuzhen ^a   Chen, Yuanyuan ^a   Kijlstra, Aize ^b  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; ALPHA5 INTEGRIN; BETA3 INTEGRIN; CD28 ANTIGEN; CD3 ANTIGEN; GAMMA INTERFERON; HERMES ANTIGEN; INTERLEUKIN 17; OSTEOPONTIN; CYTOKINE; RECOMBINANT PROTEIN;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ASSOCIATION; GENOTYPING TECHNIQUE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; VOGT KOYANAGI SYNDROME; BLOOD; DRUG EFFECT; GENETICS; GENOTYPE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MENINGOENCEPHALITIS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ANTIGENS, CD28; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; MALE; OSTEOPONTIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 80155192564     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-7539     Document Type: Article

References (49)

1. Yang P, Ren Y, Li B, Fang W, Meng Q, Kijlstra A. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. Ophthalmology. 2007;114:606-614.
2. Wakabayashi T, Morimura Y, Miyamoto Y, Okada AA. Changing patterns of intraocular inflammatory disease in Japan. Ocul Immunol Inflamm. 2003;11:277-286.
3. Yamaki K, Gocho K, Sakuragi S. Pathogenesis of Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin. 2002;42:13-23.
4. Islam SM, Numaga J, Fujino Y, et al. HLA class II genes in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci. 1994;35: 3890-3896.
5. Gocho K, Kondo I, Yamaki K. Identification of autoreactive T cells in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci. 2001; 42:2004-2009.
6. Yamaki K, Gocho K, Hayakawa K, Kondo I, Sakuragi S. Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease. J Immunol. 2000;165:7323-7329.
7. Wang KX, Denhardt DT. Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev. 2008;19:333-345.
8. Murugaiyan G, Mittal A, Weiner HL. Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4(+) T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis. J Immunol. 2008;181:7480-7488.
9. Clegg DO, Wingerd KL, Hikita ST, Tolhurst EC. Integrins in the development, function and dysfunction of the nervous system. Front Biosci. 2003;8:d723-d750.
10. Morimoto J, Kon S, Matsui Y, Uede T. Osteopontin; as a target molecule for the treatment of inflammatory diseases. Curr Drug Targets. 2010;11:494-505.
11. Agnholt J, Kelsen J, Schack L, Hvas CL, Dahlerup JF, Sorensen ES. Osteopontin, a protein with cytokine-like properties, is associated with inflammation in Crohn's disease. Scand J Immunol. 2007;65: 453-460.
12. Comabella M, Pericot I, Goertsches R, et al. Plasma osteopontin levels in multiple sclerosis. J Neuroimmunol. 2005;158:231-239.
13. Sennels H, Sorensen S, Ostergaard M, et al. Circulating levels of osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor-κB ligand, and high-sensitivity C-reactive protein in patients with active rheumatoid arthritis randomized to etanercept alone or in combination with methotrexate. Scand J Rheumatol. 2008;37:241-247.
14. Wong CK, Lit LCW, Tam LS, Li EK, Lam CWK. Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus. Rheumatology. 2005; 44:602-606.
15. Hikita ST, Vistica BP, Jones HR, et al. Osteopontin is proinflammatory in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci. 2006;47:4435-4443.
16. Kitamura M, Iwabuchi K, Kitaichi N, et al. Osteopontin aggravates experimental autoimmune uveoretinitis in mice. J Immunol. 2007; 178:6567-6572.
17. Hur EM, Youssef S, Haws ME, Zhang SY, Sobel RA, Steinman L. Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat Immunol. 2007;8:74-83.
18. O'Regan AW, Nau GJ, Chupp GL, Berman JS. Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks. Immunol Today. 2000;21:475-478.
19. Chen G, Zhang X, Li R, et al. Role of osteopontin in synovial Th17 differentiation in rheumatoid arthritis. Arthritis Rheum. 2010;62: 2900-2908.
20. Heilmann K, Hoffmann U, Witte E, et al. Osteopontin as two-sided mediator of intestinal inflammation. J Cell Mol Med. 2009;13:1162-1174.
21. Liu X, Yang P, Lin X, et al. Inhibitory effect of cyclosporin A and corticosteroids on the production of IFN-gamma and IL-17 by T cells in Vogt-Koyanagi-Harada syndrome. Clin Immunol. 2009; 131:333-342.
22. O'Doherty C, Roos IM, Antiguedad A, Aransay AM, Hillert J, Vandenbroeck K. ITGA4 polymorphisms and susceptibility to multiple sclerosis. J Neuroimmunol. 2007;189:151-157.
23. Niino M, Kikuchi S, Fukazawa T, Yabe I, Tashiro K. Genetic polymorphisms of osteopontin in association with multiple sclerosis in Japanese patients. J Neuroimmunol. 2003;136:125-129.
24. Hollis-Moffatt JE, Rowley KA, Phipps-Green AJ, et al. The ITGAV rs3738919 variant and susceptibility to rheumatoid arthritis in four Caucasian sample sets. Arthritis Res Ther. 2009;11:R152.
25. D'Alfonso S, Barizzone N, Giordano M, et al. Two single-nucleotide polymorphisms in the 5́ and 3́ ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum. 2005;52:539-547.
26. Mathias RA, Gao P, Goldstein JL, et al. A graphical assessment of p-values from sliding window haplotype tests of association to identify asthma susceptibility loci on chromosome 11q. BMC Genet. 2006;7:38.
27. Thompson EE, Pan L, Ostrovnaya I, et al. Integrin beta 3 genotype influences asthma and allergy phenotypes in the first 6 years of life. J Allergy Clin Immunol. 2007;119:1423-1429.
28. Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647-652.
29. Ishiyama M, Tominaga H, Shiga M, Sasamoto K, Ohkura Y, Ueno K. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull. 1996;19:1518-1520.
30. Chu M, Yang P, Hou S, Li F, Chen Y, Kijlstra A. Behçet's disease exhibits an increased osteopontin serum level in active stage but no association with osteopontin and its receptor gene polymorphisms. Hum Immunol. 2011;72:525-529.
31. Lund SA, Giachelli CM, Scatena M. The role of osteopontin in inflammatory processes. J Cell Commun Signal. 2009;3:311-322.
32. O'Regan AW, Hayden JM, Berman JS. Osteopontin augments CD3-mediated interferon-gamma and CD40 ligand expression by T cells, which results in IL-12 production from peripheral blood mononuclear cells. J Leukoc Biol. 2000;68:495-502.
33. Kase S, Yokoi M, Saito W, et al. Increased osteopontin levels in the vitreous of patients with diabetic retinopathy. Ophthalmic Res. 2007;39:143-147.
34. Gomez-Ambrosi J, Catalan V, Ramirez B, et al. Plasma osteopontin levels and expression in adipose tissue are increased in obesity. J Clin Endocrinol Metab. 2007;92:3719-3727.
35. Chi W, Yang P, Li B, et al. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol. 2007;119:1218-1224.
36. Sato T, Nakai T, Tamura N, et al. Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response. Gut. 2005; 54:1254-1262.
37. highregulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome. Invest Ophthalmol Vis Sci. 2008;49:3475-3482.
38. Zhao M, Jiang Y, Abrahams IW. Association of HLA antigens with Vogt-Koyanagi-Harada syndrome in a Han Chinese population. Arch Ophthalmol. 1991;109:368-370.
39. Nomura S, Matsuzaki T, Ozaki Y, et al. Clinical significance of HLA-DRB1*0410 in Japanese patients with idiopathic thrombocytopenic purpura. Blood. 1998;91:3616-3622.
40. Ivanova R, Naoumova E, Lepage V, et al. HLA-DRB1, DQA1, DQB1 DNA polymorphism in the Bulgarian population. Tissue Antigens. 1996;47:122-126.
41. Shindo Y, Ohno S, Nakamura S, Onoe K, Inoko H. A significant association of HLA-DPB1*0501 with Vogt-Koyanagi-Harada's disease results from a linkage disequilibrium with the primarily associated allele, DRB1*0405. Tissue Antigens. 1996;47:344-345.
42. Horie Y, Kitaichi N, Takemoto Y, et al. Polymorphism of IFN-γ gene and Vogt-Koyanagi-Harada disease. Mol Vis. 2007;13:2334-2338.
43. Shu Q, Yang P, Hou S, et al. Interleukin-17 gene polymorphism is associated with Vogt-Koyanagi-Harada syndrome but not with Behc ̧et's disease in a Chinese Han population. Hum Immunol. 2010; 71:988-991.
44. Horie Y, Kitaichi N, Katsuyama Y, et al. Evaluation of PTPN22 polymorphisms and Vogt-Koyanagi-Harada disease in Japanese patients. Mol Vis. 2009;15:1115-1119.
45. Marciano R, D'Annunzio G, Minuto N, et al. Association of alleles at polymorphic sites in the osteopontin encoding gene in young type 1 diabetic patients. Clin Immunol. 2009;131:84-91.
46. Han S, Guthridge JM, Harley ITW, et al. Osteopontin and systemic lupus erythematosus association: a probable gene-gender interaction. PLoS One. 2008;3:e0001757.
47. Hensiek AE, Roxburgh R, Meranian M, et al. Osteopontin gene and clinical severity of multiple sclerosis. J Neurol. 2003;250:943-947.
48. Xu G, Sun W, He D, et al. Overexpression of osteopontin in rheumatoid synovial mononuclear cells is associated with joint inflammation, not with genetic polymorphism. J Rheumatol. 2005;32:410-416.
49. Sajid M, Vijayan KV, Souza S, Bray PF. PlA polymorphism of integrin beta 3 differentially modulates cellular migration on extracellular matrix proteins. Arterioscler Thromb Vasc Biol. 2002; 22:1984-1989.